U.S. Insurance Stock News

If you are wondering whether Celanese is priced attractively right now, the key question is whether the current share price lines up with what the business looks worth on paper. The stock has had a mixed run, with a 4.6% gain over the last 30 days and a 4.9% gain year to date, set against a 40.1% decline over the past year and a 62.1% decline over three years. Investors have been reacting to a steady stream of industry updates around chemicals demand, input costs, and company specific...

KBR (NYSE:KBR) has been selected as a key contractor for the Missile Defense Agency's SHIELD defense program. The company has also been awarded the front end engineering and design work for Coastal Bend LNG's export facility. These roles expand KBR's presence in both defense systems integration and liquefied natural gas infrastructure. KBR, trading at $43.48, operates at the intersection of government services and energy projects. These contracts offer a clearer view of where management is...

Why Veeva’s new quality product matters for the stock Veeva Systems (VEEV) has launched a new environmental monitoring application tied into its LIMS and Quality Cloud products, aiming to streamline quality control and batch release for manufacturing customers ahead of its upcoming earnings report. See our latest analysis for Veeva Systems. The new environmental monitoring launch comes after a tougher stretch for the shares, with a 90 day share price return of 25.41% and a 1 year total...

Earlier in January 2026, Organon received US FDA approval of a supplemental New Drug Application for NEXPLANON, extending its contraceptive implant’s labeled duration of use from three to five years while introducing a mandatory REMS program to manage insertion and removal risks. This decision underscores how robust long-term efficacy data, including zero reported pregnancies in years four and five across a broad BMI range, can reshape the product’s clinical and commercial profile. Against...

Ardelyx, Inc. ( NASDAQ:ARDX ) shares have continued their recent momentum with a 37% gain in the last month alone. The...

Iridium Communications recently drew fresh attention after mixed brokerage commentary and new analyst coverage highlighted its slowing sales trends and pressure on free cash flow margins. The renewed research focus has sharpened debate around how effectively Iridium converts its capital spending into returns, putting management’s capital allocation decisions under a brighter spotlight. We’ll now examine how these questions about capital allocation and growth efficiency may shape Iridium...

In January 2026, Comarch announced it had signed a new contract with ExxonMobil to roll out its CLM Enterprise loyalty platform and mobile app across key European markets, expanding an earlier collaboration that began in the United States. This move deepens ExxonMobil’s push into digital customer engagement, using a unified loyalty infrastructure to sharpen fuel retail competitiveness and streamline complex, cross-country program management. Next, we’ll explore how this expanded European...

Ambitions Enterprise Management (NASDAQ:AHMA) has had a great run on the share market with its stock up by a...

Symbotic (SYM) is back on investor radar after attention around its expected year over year earnings improvement and its position as retailers ramp up spending on warehouse automation and AI systems. See our latest analysis for Symbotic. The recent pullback, including a 6.36% 1 day share price decline to US$63.12 and a 9.40% 7 day share price retreat, contrasts with Symbotic’s 88.81% 1 year total shareholder return and 301.14% 3 year total shareholder return. This suggests that longer term...

Twilio and AEG have entered a multi year partnership to use Twilio's customer data platform across key sports and entertainment properties. The collaboration covers Crypto.com Arena, the LA Kings, and the AXS ticketing platform, focusing on more personalized fan and attendee engagement. This agreement centers on real world deployments of Twilio's customer engagement tools in high profile live event settings. Twilio, NYSE:TWLO, is aligning its customer data platform with one of the largest...

Key Insights The considerable ownership by retail investors in Brera Holdings indicates that they collectively have a...

Context for Ormat Technologies (ORA) Ormat Technologies (ORA) has recently attracted investor attention after a sustained period of positive share performance over the past 3 months, prompting a closer look at how its fundamentals line up with that move. The geothermal and renewable power producer reports revenue of US$944.248m and net income of US$133.366m, with annual revenue growth of 8.2% and net income growth of 10.7%, figures that help frame current sentiment around the stock. See our...

NextEra Energy (NYSE:NEE) has signed major new long term power purchase agreements with Google and Meta Platforms. The deals focus on supplying clean electricity for AI data centers and supporting nuclear energy projects. These agreements are described as unprecedented in scale for the utility sector and have not yet been widely covered. For investors watching NYSE:NEE, these new contracts come as the stock trades at $83.51, with a 21.5% return over the past year and 11.3% over the past 5...

If you are wondering whether Netskope's current share price offers good value or still carries more risk than reward, this article is designed to walk you through what the numbers are actually saying. The stock has recently been under pressure, with a 7 day return of an 8.6% decline, a 30 day return of a 22.2% decline, and a year to date return of an 11.3% decline from a last close of US$14.99. Recent news coverage around Netskope has focused on providing evergreen analysis for investors,...

Moderna and Merck reported five year follow up data from the Phase IIb KEYNOTE-942/mRNA-4157-P201 trial of intismeran autogene (mRNA-4157) plus Keytruda in high risk melanoma. The personalized mRNA based cancer therapy showed a substantial reduction in the risk of tumor recurrence or death compared with Keytruda alone. The long term data highlight sustained efficacy and safety for Moderna’s mRNA cancer vaccine approach. For Moderna (NasdaqGS:MRNA), this oncology update comes with the stock...

Revolve Group has opened a new immersive flagship store at The Grove in Los Angeles, uniting its REVOLVE and FWRD brands across apparel, accessories, beauty, home, and an expanded men’s offering, along with authenticated pre-owned luxury handbags. The concept store doubles as an experiential showroom, using flexible, architecturally driven design to support complex multi-brand merchandising and deepen customer engagement across both premium contemporary and luxury segments. We’ll now examine...

If you are wondering whether Chagee Holdings at US$12.09 offers good value or is priced for perfection, you are in the right place to get a clear, valuation focused view. Over the short term the stock has seen a 0.4% decline over 7 days, a 2.9% decline over 30 days, and a 1.8% decline year to date, which may have shifted how some investors see its risk and opportunity. Recent coverage has centered on Chagee Holdings as it gains attention as a listed tea focused consumer services business...

Key Insights The projected fair value for Upwork is US$30.77 based on 2 Stage Free Cash Flow to Equity Upwork's...

The Morning Bull - US Market Morning Update Wednesday, Jan, 21 2026 US stock futures are pointing higher this morning, with contracts linked to the S&P 500 and Nasdaq 100 up around 0.4%, as investors weigh a jump in government bond yields against a softer US hiring signal. The 10 year US Treasury yield is at 4.29%, the highest since August, which means borrowing costs across the economy are staying relatively expensive for mortgages, car loans and corporate debt. At the same time, a private...

Recent share performance and what it might mean for investors Yum! Brands (YUM) shares have moved within a relatively tight range recently, with a small 1 day decline, a modest 7 day pullback, and muted return over the past month. See our latest analysis for Yum! Brands. While the recent 1 day and 7 day share price declines suggest some near term cooling, Yum! Brands still has a positive 90 day share price return of 3.95% and a 1 year total shareholder return of 24.24%, pointing to...

Pacific Biosciences of California, Inc. ( NASDAQ:PACB ) shareholders have had their patience rewarded with a 28% share...

Why MasTec is on investors' radar today MasTec (MTZ) has drawn attention after recent share moves, with the stock showing a mix of single day softness and stronger performance over the past week, month and past 3 months. For investors, that price action raises practical questions about how MasTec’s current valuation lines up with its reported revenue of US$13.8b, net income of US$331.1m and the company’s role across multiple North American infrastructure markets. See our latest analysis for...

If you are wondering whether Williams-Sonoma at around US$205.89 is offering good value today or asking too much, you are not alone. The stock has seen a 7.9% return over the last 30 days and 9.6% year to date, while the 1-year return is close to flat at a 0.4% decline, which can change how the market views its growth potential and risk. Over a longer stretch, the share price shows a 260.9% return over 3 years and 231.8% over 5 years, which frames the recent moves in a very different light...

Key Insights Institutions' substantial holdings in Conduent implies that they have significant influence over the...